![Scott Platshon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Platshon
Director de Operaciones en
PANACEA ACQUISITION CORP. II
.
Perfil
Mr. Scott B. Platshon is a Chief Business Officer & Executive Vice President at Zymeworks, Inc., a Chief Operating Officer at Panacea Acquisition Corp.
II and a Partner at Ecor1 Capital LLC /Venture Capital/.
He is on the Board of Directors at Theravance Biopharma, Inc., Ajax Therapeutics, Inc. and Kumquat Biosciences, Inc. Mr. Platshon was previously employed as an Independent Director by Silverback Therapeutics, Inc., a Chief Operating Officer by Panacea Acquisition Corp., and a Partner by EcoR1 Capital, LLC.
He also served on the board at Terremoto Biosciences, Inc. He received his undergraduate degree from Stanford University.
Cargos activos de Scott Platshon
| Empresas | Cargo | Inicio |
|---|---|---|
| PANACEA ACQUISITION CORP. II | Director de Operaciones | 01/01/2021 |
| ZYMEWORKS INC. | Corporate Officer/Principal | 09/04/2026 |
| THERAVANCE BIOPHARMA | Director/Miembro de la Junta | 23/09/2026 |
Ajax Therapeutics, Inc.
 Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Director/Miembro de la Junta | 01/05/2021 |
Kumquat Biosciences, Inc.
 Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Director/Miembro de la Junta | 01/02/2021 |
Antiguos cargos conocidos de Scott Platshon.
| Empresas | Cargo | Fin |
|---|---|---|
EcoR1 Capital, LLC
 EcoR1 Capital, LLC Investment ManagersFinance EcoR1 invests (long and short) in securities, consisting principally, but not solely, of equity and equity-related securities that are issued by biotechnology companies globally. | Analyst-Equity | 01/03/2026 |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Director/Miembro de la Junta | 01/12/2024 |
| ARS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | - |
Panacea Acquisition Corp.
 Panacea Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Director de Operaciones | - |
Formación de Scott Platshon.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
90
Relaciones de 1er grado
10
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EcoR1 Capital, LLC
EcoR1 Capital, LLC Investment ManagersFinance EcoR1 invests (long and short) in securities, consisting principally, but not solely, of equity and equity-related securities that are issued by biotechnology companies globally. | Finance |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Ajax Therapeutics, Inc.
Ajax Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in R&D, clinical trial and manufactures hematologic cancer therapeutics | Commercial Services |
Kumquat Biosciences, Inc.
Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Panacea Acquisition Corp.
Panacea Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Panacea Acquisition Corp. II
 Panacea Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Bolsa de valores
- Insiders
- Scott Platshon
